Anthropic files confidentially for IPO

Anthropic has confidentially filed for a U.S. IPO after recently raising $65 billion at a $965 billion post-money valuation, signaling a major step toward public markets. The article also highlights SpaceX's expected June 4 roadshow and potential $75 billion raise at a $1.75 trillion valuation, alongside OpenAI's plans to file confidentially and potentially go public as early as September. The piece underscores a potentially breakout year for U.S. IPOs, especially in AI and other high-profile private tech names.

Analysis

This is not just an IPO pipeline story; it is a signal that the private-market liquidity window is reopening for the highest-quality AI assets, which should compress the discount rate applied to late-stage private comps. The second-order winner is the underwriting ecosystem: Goldman and Morgan Stanley gain from a multi-quarter franchise cycle, but the bigger effect is fee-pool expansion across ECM, convertibles, and hedging flows as these names begin to trade and require active risk management. If the first marquee AI float prices well, expect a reflexive re-rating of adjacent private AI vendors and a wave of tender offers/secondary sales before formal listings.

The key risk is that these deals become a sentiment peak rather than a launch point. When a handful of deeply private, heavily funded companies simultaneously test public markets, the market often discovers that “AI growth” is not the same as “AI monetization,” and any post-IPO multiple compression could freeze the rest of the pipeline for 1-2 quarters. That would hurt the bankers most after the first deal, because the advisory fees are immediate while follow-on activity depends on aftermarket stability.

The contrarian read is that the biggest opportunity may not be the issuers but the gatekeepers and liquidity providers that benefit from volatility without taking long-duration valuation risk. IPO scarcity has kept ECM franchises under-earning versus historical norms; a credible restart can add meaningfully to 2026 league-table economics, especially if roadshows accelerate into a tight calendar. But if macro risk or a weak debut forces pricing cuts, the market will quickly pivot from celebrating AI dominance to questioning the durability of these valuations, and the entire issuance complex could pause.

Key Decisions for Investors

• Long GS / MS into the IPO calendar, 3-6 month horizon: the setup supports higher ECM fees, syndicate activity, and trading volumes; best expressed on pullbacks rather than chasing day-one enthusiasm.
• Buy GS Jan-2027 calls or call spreads: asymmetric exposure to a multi-deal IPO cycle with limited downside versus outright equity; best if the first two marquee listings stabilize in aftermarket trading.
• Short a basket of over-extended late-stage private AI proxies via listed software/AI software names with no near-term IPO catalyst: if the public-market tape turns skeptical, valuation compression should hit the weakest monetizers first.
• Pair long MS / short a capital-light tech index basket if volatility spikes around the first listings: MS should benefit more from advisory and issuance momentum, while the short hedges a general risk-off reaction to failed pricing.
• Set a tactical alert for first-day IPO performance: if the initial AI float trades down materially from issue price, reduce banker exposure by 25-30% as the pipeline risk shifts from optionality to delay.